Remdesivir
COVID-19: Highly concentrated antibody solution not effective treatment - study
The trial, backed by Dr. Anthony Fauci's NIAID, tested the combination of anti-coronavirus hyperimmune intravenous immunoglobulin and remdesivir.
‘Weeks, not months:’ Scientists develop ambitious pandemic response plan
WHO advises against Gilead's remdesivir for all hospitalized COVID-19 patients
Countries where remdesivir is approved or supported for treating COVID-19
Sales of first big COVID-19 drug, remdesivir, may disappoint - analysis
"A lot of people were worried about the supply and wanted to keep remdesivir for their worst-case patients."
Remdesivir did not cut hospital stay, mortality for COVID-19 - WHO study
The WHO did not comment on the FT report, saying the results of its study were not yet public.
Study confirms benefits of using Remdesivir on COVID-19 patients
The drug is used for its ability to hinder the virus's ability to reproduce, and has been attributed to shorter hospital stays for patients receiving it in trials.
Antibodies, Remdesivir, Vitamin D: Unpacking Trump’s COVID-19 treatment
Trump received a single eight-gram dose of Regeneron's polyclonal antibody cocktail, REG-COV2, Conley said, and the company confirmed in a statement sent to "The Jerusalem Post."
US hospitals turn down remdesivir, limit use to sickest COVID-19 patients
The Food and Drug Administration has allowed more liberal remdesivir use, but 6 out of 8 major hospital systems contacted by Reuters said they were not using it for moderate cases.
FDA approves expanded use of remdesivir in moderate COVID-19 patients
The drug was authorized in May for use in patients with a severe form of the illness, after trial data showed the antiviral drug helped shorten hospital recovery time.
Israel secures more Remdesivir to treat COVID-19 patients
Several hospitals, including Sheba Medical Center at Tel Hashomer and Rambam Medical Center in Haifa, had reported they were out.
Israel running low on Remdesivir, drug used in treating COVID-19 patients
“We are trying to get a hold of it,” Sheba Medical Center’s Galia Rahav told The Jerusalem Post. She said the US President Donald Trump “bought all of it and one of it is left for the whole world.”
Gates: COVID-19 meds should to go to those in need, not 'highest bidder'
"We need leaders to make these hard decisions about distributing based on equity, not just on market-driven factors."
Gilead says additional data on remdesivir shows improved clinical recovery
Findings from the analysis of its late-stage study showed that 74.4% of remdesivir-treated patients recovered by Day 14 versus 59.0% of patients receiving standard of care, the company said.
Gilead's coronavirus antiviral remdesivir gets conditional EU clearance
Remdesivir is in high demand after the intravenously-administered medicine helped to shorten hospital recovery times in a clinical trial.